Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.70 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.70 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL121501 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL15420876 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL121500 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL2509561 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL15420877 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL27709907 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| Water SCHEMBL9548430 | 0.98 | PTGS1 (0.68) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL29265136 | 0.98 | PTGS1 (0.68) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| SCHEMBL28993717 | 0.98 | PTGS1 (0.68) | PTGS1GSTK1NOD1FOLH1ALOX15 | |
| Cysteine SCHEMBL5355161 | 0.97 | PTGS1 (0.67) | PTGS1GSTK1NOD1FOLH1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59192088-A | — | — | None | — | — | JP | disclosed |
| JP-1228473-A | — | — | None | — | — | JP | disclosed |
| US-20230136465-A1 | PLANT-BASED CHICKEN FLAVORING AGENT COMPOSITION | NotCo Delaware AI, LLC | 2023-05-04 | — | — | US | disclosed |
| EP-4161498-A1 | TREATMENT OF CYSTINOSIS | NaCuity Pharmaceuticals, Inc. (US) | 2023-04-12 | — | — | EP | disclosed |
| EP-4093389-A1 | PRODRUG FOR THE TREATMENT OF DISEASE AND INJURY OF OXIDATIVE STRESS | NaCuity Pharmaceuticals, Inc. (US) | 2022-11-30 | — | — | EP | disclosed |
| US-11504413-B2 | Multi-nutrient composition | EXERKINE CORPORATION (CA) | 2022-11-22 | — | — | US | disclosed |
| WO-2022204221-A1 | TREATMENT OF FERROPTOSIS | NACUITY PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |
| EP-4000612-A1 | TREATMENT OF RETINITIS PIGMENTOSA WITH N-ACETYLCYSTEINE AMIDE | The Johns Hopkins University (US) | 2022-05-25 | — | — | EP | disclosed |
| US-20220062368-A1 | Weight Management Composition | MCMASTER UNIVERSITY (CA) | 2022-03-03 | — | — | US | disclosed |
| US-11167001-B2 | Weight management composition | EXERKINE CORPORATION (CA) | 2021-11-09 | — | — | US | disclosed |
| US-20090042822-A1 | METHOD TO ENHANCE DELIVERY OF GLUTATHIONE AND ATP LEVELS IN CELLS | BIOCEUTICALS, INC. (US) | 2009-02-12 | — | — | US | disclosed |
| EP-0387067-B1 | Novel recombinant DNA and method for production of physiologically active substance | KIKKOMAN CORP (JP) | 1994-08-31 | — | — | EP | disclosed |
| EP-0387067-A1 | Novel recombinant DNA and method for production of physiologically active substance | KIKKOMAN CORPORATION (JP) | 1990-09-12 | — | — | EP | disclosed |
| JP-H01228473-A | PRODUCTION ON NOVEL RECOMBINANT DNA AND GLUTATHIONE | KIMURA HIKARI | 1989-09-12 | — | — | JP | disclosed |
| US-4596775-A | Escherichia coli which produces gamma-glutamyl-L-cysteine synthetase | AKIRA KIMURA (JP) | 1986-06-24 | — | — | US | disclosed |
| US-4596775-A | Escherichia coli which produces gamma-glutamyl-L-cysteine synthetase | AKIRA KIMURA (JP) | 1986-06-24 | — | — | US | disclosed |
| JP-S59192088-A | PLASMID FORMED BY GENE RECOMBINATION AND PREPARATION OF GLUTHATHIONE BY IT | KIMURA HIKARI | 1984-10-31 | — | — | JP | disclosed |
| EP-0071485-A2 | Novel microorganisms derived from microorganisms of the genus Escherichia by mutation and their use in the preparation of glutathione | Kimura, Akira (JP) | 1983-02-09 | — | — | EP | disclosed |
| EP-0071485-A2 | Novel microorganisms derived from microorganisms of the genus Escherichia by mutation and their use in the preparation of glutathione | Kimura, Akira (JP) | 1983-02-09 | — | — | EP | disclosed |
| EP-0071486-A2 | Novel microorganisms of the genus Eschericia, hybrid DNA for use in their production and the use of the microorganisms in the preparation of glutathione | Kimura, Akira (JP) | 1983-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042822-A1 | METHOD TO ENHANCE DELIVERY OF GLUTATHIONE AND ATP LEVELS IN CELLS | GSR, TXNRD2, TXNRD1 | PTGS1 435/4885GSTK1 36/4885NOD1 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.